GV

GV

USD

Visionary Holdings Inc. Common Shares

$1.470+0.030 (2.083%)

Real-time Price

Consumer Defensive
Education & Training Services
Canada

Price Chart

Loading Chart...

Key Metrics

Market Metrics
Company Fundamentals
Trading Stats

Market Metrics

Open

$1.440

High

$1.490

Low

$1.420

Volume

0.03M

Company Fundamentals

Market Cap

6.0M

Industry

Education & Training Services

Country

Canada

Trading Stats

Avg Volume

1.91M

Exchange

NCM

Currency

USD

52-Week Range

Low $1.022Current $1.470High $9.6

Related News

PR Newswire

Visionary Holdings (Nasdaq: GV) Launches Stem Cell-Based Anti-Aging Product Line, Accelerating Expansion into Asia's Premium Regenerative Medicine Market

Visionary Holdings Inc. ("GV" or the "Company"), a technology-driven multinational enterprise listed on Nasdaq (Nasdaq: GV), today announced that its ...

View more
Visionary Holdings (Nasdaq: GV) Launches Stem Cell-Based Anti-Aging Product Line, Accelerating Expansion into Asia's Premium Regenerative Medicine Market
PR Newswire

Visionary Holdings Inc. Announces Successful Leadership Transition: Elite Governance Team Leads the Way, Standardized Structure Empowers High-Quality Development

At 10:00 a.m. (Eastern Time, USA) on November 3, 2025, Visionary Holdings Inc. (hereinafter referred to as the "Company", NASDAQ: GV) successfully...

View more
Visionary Holdings Inc. Announces Successful Leadership Transition: Elite Governance Team Leads the Way, Standardized Structure Empowers High-Quality Development
PR Newswire

Visionary Holdings Inc. Receives Nasdaq Notification Regarding Delayed Form 20-F Filing

Visionary Holdings Inc. (Nasdaq: GV) ("Visionary" or the "Company"), a private education service provider integrating technology and innovation,...

View more
Visionary Holdings Inc. Receives Nasdaq Notification Regarding Delayed Form 20-F Filing
PR Newswire

Visionary Holdings Launches Toronto-Based Joint Venture to Drive Global Commercialization of Innovative Stem Cell Therapy for Diabetes Remission, Targeting a $150 Billion Market Opportunity

Visionary Holdings Inc. ("GV" or the "Company"), a technology-driven multinational enterprise listed on Nasdaq (Nasdaq: GV), today announced the...

View more
Visionary Holdings Launches Toronto-Based Joint Venture to Drive Global Commercialization of Innovative Stem Cell Therapy for Diabetes Remission, Targeting a $150 Billion Market Opportunity